Hem Securities | Nseguide.com

Quotes with Resistance & Support

Market Information

Buy Divis Labs, target of Rs 1370: Hem Securities

Posted on: June 25th 2009 in Brokerage Recommendations.

Hem Securities has initiated a buy rating on Divi’s Laboratories with a target price of Rs 1370 in its research report. “Being a pioneer in the API and CRAMS segment, Divi’s Laboratories has posted tremendous growth over the past few years. With the leadership in dextrometh…

Read More..

Buy Colgate; target of Rs 740: Hem Securities

Posted on: June 8th 2009 in Brokerage Recommendations.

Hem Securities has maintained its buy rating on Colgate Palmolive with a price target of Rs 740 in its report dated June 6, 2009. “Colgate Palmolive has performed well in Q4FY09 with its topline and bottomline surging at a whopping rate of 21% and 39% respectively. The operating pr…

Read More..

Buy Dishman Pharma, target of Rs 230: Hem Securities

Posted on: May 30th 2009 in Brokerage Recommendations.

Hem Securities has recommended a buy rating on Dishman Pharmaceuticals & Chemicals with price target of Rs 230 in its May 28, 2009 research report. “The company is a leader in CRAM business amongst the largest Indian pharmaceutical companies. Moreover, in global crisis and wea…

Read More..

Buy Tata Tea, target of Rs 820: Hem Securities

Posted on: April 20th 2009 in Brokerage Recommendations.

Hem Securities has reiterated a buy rating on Tata Tea with a target price of Rs 820 in its April 17, 2009 research report. “Tata Tea has announced to acquire 51 per cent stake in Grand, a Russia’s tea and coffee major, through one of its overseas subsidiaries, in partnership …

Read More..

Buy GSK Pharma, target of Rs 1340: Hem Securities

Posted on: April 19th 2009 in Brokerage Recommendations.

Hem Securities has initiated a buy rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 1340 in its April 16, 2009 research report. “GlaxoSmithKline Pharmaceuticals has registered good set of numbers for the quarter ended December 2008. …

Read More..

Buy ESS DEE Aluminium, target of Rs 205: Hem Securities

Posted on: April 7th 2009 in Brokerage Recommendations.

Hem Securities has recommended a buy rating on ESS DEE Aluminium with a price target of Rs 205 in its April 4, 2009 research report. “Ess Dee Aluminium Limited has recently acquired India Foils Limited, a Vedanta Group, is planning to reopen the India Foils’ Hoera plant. …

Read More..

Buy Aban Offshore, target of Rs 484: Hem Securities

Posted on: March 30th 2009 in Brokerage Recommendations.

Hem Securities has recommended a buy rating on Aban Offshore with a price target of Rs 484 in its March 28, 2009 research report. “Aban Offshore Ltd., has two business segments: Offshore Oil Drilling and Production services, and Wind Power generation. …

Read More..